The Directorate General of Drug Administration (DGDA) did not find any problem with a batch of Napa syrup of Beximco Pharmaceuticals Limited after running a series of lab tests for quality.
The tests were performed following allegations of the deaths of two children in Ashuganj of Brahmanbaria after consuming Napa syrup.
This information was given by the Director-General of DGDA, Brigadier General Mohammad Yusuf at a press conference on Monday on the issue highlighting infant mortality in Napa Syrup.
He said that Beximco Pharmaceuticals Ltd had tested the quality of two more syrups collected from the accused stores, including two of the three batches, and found that the quality of the medicine was correct.
“Eight bottles were collected from the store. The results have been positive in all of them. Nothing harmful was found in these syrups,” he said.
On the night of March 10, two children named Yasin Khan (7) and Morsalin Khan (5) of Durgapur village of Ashuganj upazila of Brahmanbaria died. Their mother, Lima Begum, told reporters that they died after consuming napa syrup.
Two separate committees were formed to investigate the incident. A committee has been formed from the Chittagong Divisional Office of the Health Directorate headed by Dr Mohiuddin, Director of Comilla Medical College Hospital. The other members of the committee are Dr Mir Mubarak Hossain, Civil Surgeon, Comilla and Dr Rafiq-us-Chalehin, Civil Surgeon, Feni.
Besides, a three-member separate inspection committee headed by Dr Nupur Saha, Ashuganj Upazila Health, was formed from Brahmanbaria Civil Surgeon's Office.
Citing the information of the committee's investigation report, the Directorate General of Drug Administration stated that although batch No. 32113121-68000 of Napa Syrup of Beximco Pharmaceuticals Limited had expired, the quality of this syrup remained unchanged.